Results 121 to 130 of about 13,805 (198)

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment. [PDF]

Clin Cancer Res, 2022
Kleinendorst SC, Oosterwijk E, Bussink J, Westdorp H, Konijnenberg MW, Heskamp S.   +5 more
europepmc   +1 more source

Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with ²¹¹At Using Implanted Mouse Tumor. [PDF]

Int J Mol Sci, 2022
Yonekura Y, Toki H, Watabe T, Kaneda-Nakashima K, Shirakami Y, Ooe K, Toyoshima A, Nakajima H, Tomiyama N, Bando M.   +9 more
europepmc   +1 more source

Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade. [PDF]

Front Nucl Med
Haugh KN, Sanwick AM, Chaple IF.
europepmc   +1 more source

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies. [PDF]

Eur J Nucl Med Mol Imaging, 2023
Privé BM, Boussihmad MA, Timmermans B, van Gemert WA, Peters SMB, Derks YHW, van Lith SAM, Mehra N, Nagarajah J, Heskamp S, Westdorp H.   +10 more
europepmc   +1 more source

Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. [PDF]

Neuro Oncol
Weller M, Albert NL, Galldiks N, Bink A, Preusser M, Sulman EP, Treyer V, Wen PY, Tonn JC, Le Rhun E.   +9 more
europepmc   +1 more source

Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential? [PDF]

Neuro Oncol
Le Rhun E, Albert NL, Hüllner M, Franceschi E, Galldiks N, Karschnia P, Minniti G, Weiss T, Preusser M, Ellingson BM, Weller M.   +10 more
europepmc   +1 more source

A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT). [PDF]

Pharmaceutics, 2022
Spoormans K, Crabbé M, Struelens L, De Saint-Hubert M, Koole M.   +4 more
europepmc   +1 more source

Evaluation of ¹⁷⁷Lu-Labeled Lipiodol as a Targeted Radionuclide Therapy for Hepatocellular Carcinoma in a Preclinical Xenograft Model. [PDF]

Mol Imaging Biol
Kono Y, Utsunomiya K, Shiraishi T, Kan N, Shiojima I, Maruyama K, Tanigawa N.   +6 more
europepmc   +1 more source

A fast Monte Carlo cell-by-cell simulation for radiobiological effects in targeted radionuclide therapy using pre-calculated single-particle track standard DNA damage data. [PDF]

Front Nucl Med, 2023
Lim A, Andriotty M, Yusufaly T, Agasthya G, Lee B, Wang C.   +5 more
europepmc   +1 more source

Relevance and implementation of patient-specific dosimetry in targeted radionuclide therapy

BIO Web of Conferences, 2019
Bardiès Manuel
doaj   +1 more source